Novo Nordisk Inc. provided funding support for the FORWARD: Focus on Obesity Education curriculum. FORWARD was developed by Novo Nordisk Inc., in collaboration with a steering committee of obesity clinician experts, to address gaps in obesity education and support the preparation of future health care providers to diagnose, care for and treat people with obesity. The goal of FORWARD is to present a complete, accurate, non-promotional and evidence-based picture of the current state of obesity.

FORWARD Obesity Education Curriculum

Meticulously built on the foundation of the OMEC Obesity Competencies

Over 6 hours of educational content, available free of charge

Each module is available as PowerPoint slides, video lectures or podcast audio to support various learning styles

13 self contained modules with integrated multiple choice assessments

Expert Steering Committee - 2025

Expert Steering Committee - 2025

FORWARD Curriculum Modules

1

Introduction to Obesity     

15 mins

2

Pathophysiology of Obesity: Appetite Dysregulation, and Metabolic and Hormonal Adaptation

25 mins

3

Pathophysiology of Obesity: Genetics, Environmental, and Social Causes

15 mins

4

Addressing Stigma and Bias in Caring for Patients with Obesity

15 mins

5

Communication in Obesity Care: With Patients, Family Members, and Healthcare Professionals

20 mins

6

Obesity-Related Complications and the Impact of Weight Loss

50 mins

7

Caring for Patients with Obesity

20 mins

8

Lifestyle Modifications and Behavioral Interventions for Obesity

15 mins

9

FDA-Approved Anti-Obesity Medications for Chronic Weight Management

30 mins

10

Metabolic and Bariatric Surgery

15 mins

11

Pediatric and Adolescent Obesity Management

15 mins

12

Special Considerations for Weight Management Across Adult Populations​​​

30 mins

13

From Theory to Practice: Treating Patients with Obesity

15 mins

View module details

FORWARD Curriculum Modules

1

Introduction to Obesity

15 mins

2

Pathophysiology of Obesity: Appetite Dysregulation, and Metabolic and Hormonal Adaptation

25 mins

3

Pathophysiology of Obesity: Genetics, Environmental, and Social Causes

15 mins

4

Addressing Stigma and Bias in Caring for Patients with Obesity

15 mins

5

Communication in Obesity Care: With Patients, Family Members, and Healthcare Professionals

20 mins

6

Obesity-Related Complications and the Impact of Weight Loss

50 mins

7

Caring for Patients with Obesity

20 mins

8

Lifestyle Modifications and Behavioral Interventions for Obesity

15 mins

9

FDA-Approved Anti-Obesity Medications for Chronic Weight Management

30 mins

10

Metabolic and Bariatric Surgery

15 mins

11

Pediatric and Adolescent Obesity Management

15 mins

12

Special Considerations for Weight Management Across Adult Populations

30 mins

   

View module details

Novo Nordisk Medical is a trademark of Novo Nordisk Health Care AG.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
Non-US Health Care Professionals, please go to www.novonordiskpro.com.

Top

This medical content was developed independently by a third party via an educational grant. This material is copyright protected and is provided here with permission for educational and informational purposes only and is not certified for continuing education credits.

Continue

You are now leaving the Novo Nordisk Medical website.

Our Privacy Policy applies only to this and other websites maintained by Novo Nordisk. Links are provided as a public service and for informational purposes only. No endorsement is made or implied. Click "Continue" to leave this site.

Continue

GATED INTERSTITAL  

You are now leaving the Novo Nordisk Medical website.

Our Privacy Policy applies only to this and other websites maintained by Novo Nordisk. Links are provided as a public service and for informational purposes only. No endorsement is made or implied. Click "Continue" to leave this site.

ACCESS DENIED

Our Privacy Policy applies only to this and other websites maintained by Novo Nordisk. Links are provided as a public service and for informational purposes only. No endorsement is made or implied. Click "Continue" to leave this site.